Product image of Nocdurna (Desmopressin) supplied by GNH India

Nocdurna

Active Ingredient:
Desmopressin
Origin:
EU

Nocdurna (Desmopressin)

Desmopressin, the active ingredient in Nocdurna, is a vasopressin analog presented as a 0.2 mg sublingual tablet for sublingual use. It is indicated for the management of nocturnal enuresis in children and adults, helping to reduce bedwetting episodes.

GNH India supplies Nocdurna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled distribution across multiple markets. The company adheres to EU GMP standards and provides regulatory support for importers. Our global logistics network enables timely delivery while maintaining product integrity.

Manufacturer / TM Owner

Ferring Läkemedel Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acts on the antidiuretic pathway to reduce urine production during sleep.

  • Nocturnal enuresis: decreases the number of wet nights by increasing water reabsorption in the kidneys.
  • Central diabetes insipidus: replaces deficient antidiuretic hormone to reduce excessive urine output.
  • Primary nocturnal polyuria: limits nighttime urine volume, improving sleep continuity.

How It Works

  • Desmopressin is a selective V2‑receptor agonist that binds to renal collecting‑duct cells, stimulating cyclic AMP production. This enhances the insertion of aquaporin‑2 water channels into the apical membrane, promoting water reabsorption and concentrating urine, thereby reducing diuresis.

Side Effects

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Headache: mild to moderate pain often reported during early treatment.
  • Nausea: transient stomach upset that usually resolves without intervention.
  • Nasal congestion: sensation of blocked nasal passages.
  • Abdominal discomfort: mild cramps or pain.
  • Flushing: temporary reddening of the skin.
  • Hyponatremia (mild): low sodium levels without neurological symptoms.

Serious or Rare Side Effects

  • Severe hyponatremia: can lead to confusion, seizures, or coma.
  • Water intoxication: excessive fluid retention causing edema.
  • Allergic reaction: rash, itching, or swelling of the face and throat.
  • Thromboembolic events: rare clot formation in veins.
  • Hypotension: marked drop in blood pressure.
  • Seizures: neurological events associated with electrolyte imbalance.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient-specific risk factors.

  • Fluid restriction: limit excessive fluid intake to reduce hyponatremia risk.
  • Serum sodium monitoring: check sodium levels regularly, especially in high‑risk patients.
  • Renal function assessment: adjust use in patients with impaired kidney function.
  • Elderly caution: older adults may be more susceptible to water retention and electrolyte shifts.
  • Drug interaction review: avoid concurrent use with other antidiuretic agents.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Desmopressin may interact with several medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

  • Other antidiuretic agents (e.g., vasopressin analogs): combined use can precipitate severe hyponatremia.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase the risk of water retention and hyponatremia.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may reduce desmopressin efficacy by increasing urinary water loss.
  • Carbamazepine: can enhance desmopressin clearance, lowering its effect.
  • Alcohol: may potentiate water retention and exacerbate electrolyte disturbances.

Frequently Asked Questions

Nocdurna contains the active ingredient desmopressin and is prescribed to manage nocturnal enuresis, commonly known as bedwetting, in children and adults. By reducing nighttime urine production, it helps decrease the frequency of wet‑bed incidents.

Desmopressin is a synthetic analogue of the natural hormone vasopressin. It selectively activates V2 receptors in the renal collecting ducts, stimulating the insertion of aquaporin‑2 channels, which increases water reabsorption and concentrates urine, thereby lowering urine output.

The appropriate dose of Nocdurna is individualized by the prescribing healthcare professional based on factors such as patient age, weight, severity of enuresis, and renal function. No fixed regimen is provided here; the prescriber sets the exact dosage.

Safety data for desmopressin in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks with their physician before using Nocdurna.

To place an order, submit an enquiry on the Nocdurna product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nocdurna delivers desmopressin as a sublingual tablet, offering rapid absorption and convenient dosing compared with injectable vasopressin or oral liquid formulations. Its selective V2‑receptor activity provides targeted antidiuretic effects with a lower incidence of vasoconstrictive side effects seen with some alternatives.

Nocdurna tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Protect them from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

The tablet is placed under the tongue and allowed to dissolve completely without swallowing. Sublingual administration enables rapid absorption into the bloodstream, typically within 30 minutes. Patients should avoid eating or drinking for a few minutes after placement.

The most critical safety concerns are severe hyponatremia and water intoxication, which can lead to neurological symptoms such as confusion, seizures, or coma. Prompt monitoring of serum sodium and adherence to fluid‑restriction guidelines are essential to mitigate these risks.

Nocdurna is contraindicated in patients with existing hyponatremia, uncontrolled hypertension, severe renal impairment, or a history of water‑retention disorders. Individuals taking other antidiuretic agents or those prone to electrolyte disturbances should also avoid this medication unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.